Marcus A. Conant
Corporate Officer/Principal en The University of California, San Francisco .
Cargos activos de Marcus A. Conant
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Historial de carrera de Marcus A. Conant
Antiguos cargos conocidos de Marcus A. Conant.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Director Técnico/Científico/I+D | - | - |
| ENZO BIOCHEM, INC. | Director/Miembro de la Junta | - | - |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Marcus A. Conant
- Experiencia
